Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03315728
Other study ID # R2722A59
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 26, 2017
Est. completion date March 31, 2022

Study information

Verified date April 2022
Source Western University, Canada
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The PATHWAYS for Health Equity research program builds on the 5-year FORGE AHEAD Indigenous diabetes quality improvement research program (2013 - 2017). PATHWAYS for Health Equity, a 3-year research program (2017 - 2019), is a great opportunity to continue our important collaborative diabetes quality improvement research with an increasing number of Indigenous partnering communities and researchers and key stakeholders (collaborators, policymakers and knowledge-users). Four partnering First Nations communities will join the Pathways program to develop community-driven quality improvement initiatives championed by a Community Facilitator and supported by a Community Data Coordinator.


Description:

GOAL To improve the health and health equity of Indigenous peoples by strengthening the effectiveness, sustainability and scalability of a promising community-driven and culturally-relevant quality improvement strategy through meaningful conversations and engagement with our community partners. OBJECTIVES 1. Engage community partners and key stakeholders to support meaningful participation and leadership 2. Review, improve and adapt the diabetes quality improvement strategy with community partners 3. Evaluate the effectiveness of the adapted diabetes quality improvement strategy 4. Develop community-driven plans for sustainability and scale-up for the adapted diabetes quality improvement strategy WHY IS PATHWAYS IMPORTANT? In Canada, there are significant inequalities between the health status of Indigenous peoples and the general population concerning diabetes. Community-driven initiatives using promising diabetes quality improvement strategies can potentially reform local healthcare in Indigenous communities and improve care for those living with diabetes. WHAT IS INVOLVED IN PATHWAYS? Community-based champions called Community Facilitators and Community Data Coordinators will be trained to provide leadership and support to community-based teams to make priority improvements to diabetes programs/ services and clinical care. The 18-month quality improvement intervention includes: - educational workshops on diabetes and quality improvement - support, communication, and coaching for action planning and quality improvement - readiness consultation tools - diabetes registry & surveillance system An evaluation consisting of interviews and questionnaires may be used to understand the process of adapting the diabetes quality improvement strategy to each community's context and factors that influence the program's success. Our strong, multidisciplinary and cross-jurisdictional PATHWAYS Team includes Indigenous community representatives and healthcare providers, nonIndigenous healthcare providers, clinician scientists and academic researchers, as well as policy decision-makers and knowledge-user organizations. The timely program will provide community leaders and knowledge-users with policy recommendations and a quality improvement strategy that can be implemented, sustained and spread to Indigenous community settings and regions across Canada and internationally. COMMUNITY PARTNERS Four community partners will be engaged and will partner in the Pathways program (two in Ontario and two in Atlantic Canada). Formal Community Research Agreements will represent participation and partnership.


Recruitment information / eligibility

Status Completed
Enrollment 4
Est. completion date March 31, 2022
Est. primary completion date March 31, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Indigenous Communities in Canada: 1. On-reserve community 2. Community Band Council approval to participate and collaboration 3. Community healthcare facility approval or willingness to participate including both prevention and management/treatment arms if separate 4. Signed Community Research Agreement (including Financial Agreement) by the custodian of community medical charts, health leadership, and community leadership (if required). Access to community medical charts is required for FNDSS Patient Chart Inclusion Criteria for chart audit component: 1. Age 18 or older. 2. Diagnosed with type 2 diabetes Exclusion Criteria: Indigenous Communities: 1. Communities that are unlikely to comply with the protocol (uncooperative attitude, unlikelihood of completing the program) 2. Healthcare facility unwilling to participate or uncooperative. Patient Chart Exclusion Criteria for chart audit component: 1. Less than 18 years old 2. Diagnosed with type 1 or gestational diabetes 3. Life expectancy is less than 6 months 4. Inactive patient (no clinic visit in the last 12 months)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Quality Improvement Strategy
Quality improvement strategy The 18 month Quality Improvement Strategy includes 3 months preparation, 12 months intervention, 3 months local knowledge translation. The intervention includes Readiness Consultations to assist in understanding available resources to address and adopt diabetes and chronic disease prevention and care strategies. Community teams receive a series of 3 workshops (in-person/virtual) followed by action periods where the team carry out and evaluate PDSAs they develop to improve diabetes care. Coaching is provided by Western during the 3-4 month action periods. FNDSS is a webbased secure community portal system for communities to develop a diabetes registry/surveillance system and generate reports and plan QI initiatives.

Locations

Country Name City State
Canada Western University London Ontario

Sponsors (4)

Lead Sponsor Collaborator
Western University, Canada AstraZeneca, Canadian Institutes of Health Research (CIHR), Juvenile Diabetes Research Foundation

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Understand the influence of community context on the implementation of the QI Strategy as assessed by the Consolidated Framework for Implementation Research Qualitative information will be collected by interviews or focus groups to understand how context influences the implementation of the QI strategy. Questions on the interview are guided by the Consolidated Framework for Implementation Research, which includes questions on intervention characteristics, outer community setting, inner community setting, characteristics of individuals/teams, and implementation processes. November 2017 - April 2019
Secondary Glycated hemoglobin (A1C) Improvement in A1C will be assessed using the community's FNDSS portal. November 2017 - April 2019
See also
  Status Clinical Trial Phase
Terminated NCT02303405 - Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus Phase 2
Active, not recruiting NCT05579561 - Vegetarian Ketogenic Diet VS Omnivore Ketogenic Diet - Protocol of a Keto-vege Diet for Remission of Type 2 Diabetes N/A
Recruiting NCT03269799 - Vitamin C as an Adjunct in Periodontal Treatment in Type 2 Diabetes Mellitus Patients Phase 2